China Universal Asset Management Co., Ltd. Immunic, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
46.9MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$8.28 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.67 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.78 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$4.14 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.66 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $28.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...